-- 四川和邦生物科技（上海証券取引所：603077）は、2025年度の株主帰属純損失が5億3640万元（1株当たり0.0522元）に転落した。これは火曜日に上海証券取引所に提出された書類で明らかになった。 前年同期の株主帰属純利益は3150万元（1株当たり0.0037元）だった。 営業収益は前年同期の85億8000万元から16%減の71億9000万元となった。 この中国のバイオテクノロジー企業の株価は午後の取引で7%下落した。
Related Articles
Australia
Rothschild & Co Redburn Adjusts Price Target on Otis Worldwide to $101 From $112, Maintains Buy Rating
Otis Worldwide (OTIS) has an average rating of overweight and mean price target of $93.54, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $78.45, Change: $+0.50, Percent Change: +0.64%
$OTIS
Australia
NICE Says Bell Integration Selects CXone Platform to Support Service Desk Projects
NICE (NICE) said Monday that information technology services and consultancy Bell Integration has selected its CXone platform to back service desk and business development operations.Initial deployment will be in three sites and will support up to 1,000 employees, the company said.Financial details were not provided.NICE shares were up nearly 2% in morning trading.Price: $102.69, Change: $+2.34, Percent Change: +2.33%
$NICE
Australia
BofA Securities Adjusts Price Target on Western Digital to $495 From $415
Western Digital (WDC) has an average rating of overweight and mean price target of $387.27, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $402.91, Change: $-1.09, Percent Change: -0.27%
$WDC